Send us a text
In this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This weekโs deep dive also touches on emerging trends in GLP-1 therapy and how recent shifts may impact accessibility for patients. Whether youโre just starting your journey or a long-time follower of GLP-1 news, this episode brings you the essentials. โย
Maritide Bone Density Loss:
https://www.statnews.com/2024/11/12/amgen-maritide-obesity-drug-candidate-data/
Catalent Novo Merger:
https://www.biospace.com/deals/lilly-vs-novo-the-he-said-she-said-row-about-catalents-glp-1-work
Novo War On Compounds:
https://www.onthepen.com/post/shocking-truth-about-semaglutide-what-novo-nordisk-doesn-t-want-you-to-know
Drug Shortage Policy Reform Request (VOTE!):
https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821
ro.co/OTP
& so much moreA bi-monthly podcast where we share the stories of our Caregivers, patients and...
Listen on: Apple Podcasts ย Spotify
Support the show
DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
USE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
๐ My Amazon Affiliate Store:
https://www.amazon.com/shop/manonthemounjaroonthepen
MORE COMMUNITY!
๐บ Watch Our Weekly Live Show: onthepen.tv
๐ Discord: https://discord.gg/u4Ea8qqP
๐ค Visit Our Sponsor!
GLP-1 Ro Body Plan: https://www.ro.co/otp
Report The Shortage: https://www.ro.co/supply-tracker
Does your insurance cover GLPs? https://www.ro.com/checker
๐ฒ Contact Me: [email protected]
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepe...